Sexual function in men treated for testicular cancer

Journal of Sexual Medicine

Volumn 6, Issue 7, 2009, Pages 1979-1989

  Eberhard, Jakob ^a   Ståhl, Olof ^a   Cohn Cedermark, Gabriella ^b   Cavallin Ståhl, Eva ^a   Giwercman, Yvonne ^c   Rylander, Lars ^c   Eberhard Gran, Malin ^d   Kvist, Ulrik ^b   Fugl Meyer, Kerstin S ^b   Giwercman, Aleksander ^a,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Hypogonadism; Oncology; Sexual dysfunction; Sexual satisfaction; Sexuality; Testicular cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADULT; AGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DISTRESS SYNDROME; ERECTILE DYSFUNCTION; GERM CELL TUMOR; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PREMATURE EJACULATION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SWEDEN; AGED; CHEMICALLY INDUCED; COMPARATIVE STUDY; COMPLICATION; CONFIDENCE INTERVAL; DRUG EFFECTS; IMPOTENCE, VASCULOGENIC; LIBIDO; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; RISK; RISK FACTOR; STATISTICAL MODEL; TESTICULAR NEOPLASMS; TIME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CONFIDENCE INTERVALS; HUMANS; HYPOGONADISM; IMPOTENCE, VASCULOGENIC; LIBIDO; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; ODDS RATIO; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SWEDEN; TESTICULAR NEOPLASMS; TIME FACTORS;

EID: 67649850758     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01298.x     Document Type: Article

References (28)

1. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Stahl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fossa SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Ares LP, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part I. Eur Urol 2008; 53: 478-96.
2. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Stahl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fossa SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Paz-Ares L, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II. Eur Urol 2008; 53: 497-513.
3. Aass N, Grunfeld B, Kaalhus O, Fossa SD. Pre- and post-treatment sexual life in testicular cancer patients: A descriptive investigation. Br J Cancer 1993; 67: 1113-7.
4. Arai Y, Kawakita M, Okada Y, Yoshida O. Sexuality and fertility in long-term survivors of testicular cancer. J Clin Oncol 1997;15: 1444-8.
5. Jonker-Pool G, van Basten JP, Hoekstra HJ, van Driel MF, Sleijfer DT, Koops HS, van de Wiel HB. Sexual functioning after treatment for testicular cancer: Comparison of treatment modalities. Cancer 1997; 80: 454-64.
6. Caffo O, Amichetti M. Evaluation of sexual life after orchidectomy followed by radiotherapy for early-stage seminoma of the testis. BJU Int 1999; 83: 462-8.
7. Hartmann JT, Albrecht C, Schmoll HJ, Kuczyk MA, Kollmannsberger C, Bokemeyer C. Long-term effects on sexual function and fertility after treatment of testicular cancer. Br J Cancer 1999; 80: 801-7.
8. Rieker PP, Edbril SD, Garnick MB. Curative testis cancer therapy: Psychosocial sequelae. J Clin Oncol 1985; 3: 1117-26.
9. Stoter G, Koopman A, Vendrik CP, Struyvenberg A, Sleyfer DT, Willemse PH, Schraffordt Koops H, van Oosterom AT, ten Bokkel Huinink WW, Pinedo HM. Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin. J Clin Oncol 1989; 7: 1099-104.
10. Tinkler SD, Howard GC, Kerr GR. Sexual morbidity following radiotherapy for germ cell tumours of the testis. Radiother Oncol 1992; 25: 207-12.
11. Huddart RA, Norman A, Moynihan C, Horwich A, Parker C, Nicholls E, Dearnaley DP. Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer 2005; 93: 200-7.
12. Eberhard J, Stahl O, Giwercman Y, Cwikiel M, Cavallin-Stahl E, Lundin KB, Flodgren P, Giwercman A. Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: A longitudinal study. Hum Reprod 2004; 19: 1418-25.
13. Jonker-Pool G, Van de Wiel HB, Hoekstra HJ, Sleijfer DT, Van Driel MF, Van Basten JP, Schraffordt Koops HS. Sexual functioning after treatment for testicular cancer-Review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav 2001;30: 55-74.
14. Nazareth I, Lewin J, King M. Sexual dysfunction after treatment for testicular cancer: A systematic review. J Psychosom Res 2001; 51: 735-43.
15. Horwich A, Brada M, Nicholls J, Jay G, Hendry WF, Dearnaley D, Peckham MJ. Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours. Eur J Cancer Clin Oncol 1989; 25: 177-84.
16. Fugl-Meyer K, Lewin B, Folkhälsoinstitutet. Sex in Sweden: On the Swedish sexual life 1996. 1st edition. Stockholm: National Institute of Public Health (Folkhälsoinstitutet). 2000.
17. Eberhard J, Stahl O, Cwikiel M, Cavallin-Stahl E, Giwercman Y, Salmonson EC, Giwercman A. Risk factors for post-treatment hypogonadism in testicular cancer patients. Eur J Endocrinol 2008;158: 561-70.
18. Fugl-Meyer K, Fugl-Meyer AR. Sexual disabilities are not singularities. Int J Impot Res 2002; 14: 487-93.
19. Fugl-Meyer AR, Melin R, Fugl-Meyer KS. Life satisfaction in 18- to 64-year-old Swedes: In relation to gender, age, partner and immigrant status. J Rehabil Med 2002; 34: 239-46.
20. Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM, Wu FC. Testosterone replacement therapy: Current trends and future directions. Hum Reprod Update 2004; 10: 409-19.
21. Huyghe E, Sui D, Odensky E, Schover LR. Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center. J Sex Med 2009; 6: 149-63.
22. Nelson CJ, Shindel AW, Naughton CK, Ohebshalom M, Mulhall JP. Prevalence and predictors of sexual problems, relationship stress, and depression in female partners of infertile couples. J Sex Med 2008;5: 1907-14.
23. Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E, Martin-Morales A. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004; 1: 35-9.
24. Fegg MJ, Gerl A, Vollmer TC, Gruber U, Jost C, Meiler S, Hiddemann W. Subjective quality of life and sexual functioning after germ-cell tumour therapy. Br J Cancer 2003; 89: 2202-6.
25. Lackner J, Schatzl G, Koller A, Mazal P, Waldhoer T, Marberger M, Kratzik C. Treatment of testicular cancer: Influence on pituitary-gonadal axis and sexual function. Urology 2005; 66: 402-6.
26. Incrocci L, Hop WC, Wijnmaalen A, Slob AK. Treatment outcome, body image, and sexual functioning after orchiectomy and radiotherapy for stage I-II testicular seminoma. Int J Radiat Oncol Biol Phys 2002; 53: 1165-73.
27. Wiechno P, Demkow T, Kubiak K, Sadowska M, Kaminska J. The quality of life and hormonal disturbances in testicular cancer survivors in cisplatin era. Eur Urol 2007; 52: 1448-54.
28. Winters SJ. Diurnal rhythm of testosterone and luteinizing hormone in hypogonadal men. J Androl 1991;12: 185-90.